Potential business model for a European vaccine R&D infrastructure and its estimated socio-economic impact [version 1; peer review: 1 approved, 2 approved with reservations]

Potential business model for a European vaccine R&D infrastructure and its estimated socio-economic impact [version 1; peer review: 1 approved, 2 approved with reservations]

Background Research infrastructures are facilities or resources that have proven fundamental for supporting scientific research and innovation. However, they are also known to be very expensive in their establishment, operation and maintenance. As by far the biggest share of these costs is always bo...

Full description

Bibliographic Details
Main Authors: Nicolas Collin, Donata Medaglini, Arjen Sloots, Maria Lawrenz, Jan A.M. Langermans, Roger Le Grand, Norbert Stockhofe-Zurwieden, Francesca Morelli, Fabrice Laurent, Frédéric Lantier, Alexandre Dobly, Dennis Christensen, Joaquim Segalés, H. M. Dockrell, Mei Mei Ho, Ole Olesen, Tom H.M. Ottenhoff, Frank A.W. Verreck, Stefan Jungbluth, Sven Arnouts, Manuel J. T. Carrondo, David Morrow, Fran Van Heuverswyn, Carlos A. Guzman, Anton Ussi, Monika Slezak, Hilde Depraetere, William Martin
Format: Article
Language:English
Published: F1000 Research Ltd 2023-10-01
Series:F1000Research
Subjects:
Vaccines
research and development
research infrastructure
business model
sustainability
impact assessment
eng
Online Access:https://f1000research.com/articles/12-1401/v1

Internet

https://f1000research.com/articles/12-1401/v1

Similar Items